|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:bfsLayer
|
6
|
|
gptkbp:bfsParent
|
gptkb:Glycopyrrolate_Injection
gptkb:Robinul
|
|
gptkbp:activities
|
muscarinic receptor antagonist
|
|
gptkbp:appointed_by
|
injection
oral tablet
|
|
gptkbp:approves
|
gptkb:1980
|
|
gptkbp:can_be_used_with
|
antibiotics
antivirals
antifungals
corticosteroids
beta-agonists
|
|
gptkbp:clinical_trial
|
Phase IV
Phase III
|
|
gptkbp:composed_of
|
gptkb:chemical_compound
extraction from plants
|
|
gptkbp:contraindication
|
gptkb:sneaker
gptkb:Insurance_Company
urinary obstruction
severe ulcerative colitis
|
|
gptkbp:developed_by
|
gptkb:Boehringer_Ingelheim
|
|
gptkbp:dosage_form
|
oral solution
inhalation solution
|
|
gptkbp:excretion
|
urine
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Glycopyrrolate
|
|
gptkbp:ingredients
|
C19 H28 Br N
|
|
gptkbp:interacts_with
|
antihistamines
opioids
muscle relaxants
tricyclic antidepressants
other anticholinergics
|
|
gptkbp:invention
|
2025
|
|
gptkbp:is_available_on
|
generic version
brand name Cuvposa
brand name Robinul
|
|
gptkbp:is_used_for
|
treating peptic ulcers
preventing bradycardia
reducing salivation
treating excessive sweating
|
|
gptkbp:marketed_as
|
gptkb:Robinul_Forte
gptkb:Cuvposa
gptkb:Glycopyrrolate_Injection
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:related_to
|
gptkb:scopolamine
atropine
|
|
gptkbp:side_effect
|
dizziness
constipation
dry mouth
blurred vision
urinary retention
|
|
gptkbp:type_of
|
602-75-5
|
|
gptkbp:used_in
|
gptkb:healthcare_organization
pediatric patients
|